Corporate Finance

After Amgen steps back, Kyowa Kirin takes full control of its promising atopic dermatitis drug, rocatinlimab, betting on its unique science.

Bonaccord Capital Partners' new award highlights its success in the booming GP stakes market and validates parent company P10's strategic middle-market focus.

As Bladex prepares its Q4 2025 results, all eyes are on the bank's performance as a key indicator of regional economic health and future investment.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

BNY's long-term deal with Williams F1 signals a major strategic play ahead of the sport's 2026 rule reset. Is this the fuel for a historic comeback?

Publicly-traded xTAO Inc. upgrades its infrastructure, securing a top spot in Bittensor's high-stakes decentralized AI ecosystem. What does this mean for the future?

Swedish developer Minesto secures funding to build tidal energy farms in Taiwan, a key step in the island's ambitious renewable energy transition.

Global operator VEON partners with MindBridge, ditching old methods for AI that analyzes 100% of financial data, setting a new standard for corporate integrity.

Despite a 23.5% ROAE and surging profits driven by digital growth, Banco Santander Chile's stock fell as investors questioned its revenue outlook.

As QuantumScape nears commercialization, it adds a veteran CFO from NVIDIA and Cadence to its board, signaling a focus on financial discipline and scaling.

After a record snowstorm paralyzed the city and exposed its aging equipment, a $2 million PNC grant provides a critical boost for Pittsburgh's resilience.

A new strategic partnership aims to reshape corporate finance by combining digital engineering with an AI-driven treasury platform for global enterprises.

The federal government has announced a new benefit to help with rising food costs. Here’s what it means for your wallet and the fight against hunger.

The real estate investor's Q4 results reveal a major financing deal, new acquisitions in Poland, and a rising asset value, showcasing its robust growth.

A new patent for pixel-level document fingerprinting could revolutionize how companies handle massive data breaches, promising speed and clarity in a chaotic field.

HTX reports massive gains on new listings like RIVER, but do these surges reflect a true market recovery or high-risk bets in a fearful market?

Lexicon Pharmaceuticals raised nearly $95 million to fund its drug pipeline, but the move sent its stock plunging as investors weighed future promise against immediate dilution.

Candela unveils its Glacē, Matrix, and Vbeam Pro systems in Paris, a strategic move to dominate Europe's booming, multi-billion dollar aesthetics industry.

A new report signals a major shift as AI moves from assistant to agent. Enterprises are going autonomous, but governance and trust are the new battlegrounds.

The home decor giant stabilized H2 sales but a sharp online decline and withdrawn financial guidance reveal deeper challenges for the retailer.